Page last updated: 2024-11-04

risedronic acid and Parodontosis

risedronic acid has been researched along with Parodontosis in 2 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scully, C1

Other Studies

2 other studies available for risedronic acid and Parodontosis

ArticleYear
One drug tackles two diseases.
    British dental journal, 2005, Dec-10, Volume: 199, Issue:11

    Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Humans; Middle Aged;

2005
Potential adverse effects.
    British dental journal, 2006, Feb-11, Volume: 200, Issue:3

    Topics: Bone Density Conservation Agents; Etidronic Acid; Humans; Jaw Diseases; Osteonecrosis; Periodontal D

2006